NIH, FDA seek lessons from hepatitis B drug trial deaths
Article Abstract:
Investigators from the Food and Drug Administration and the National Institutes of Health are looking into the deaths of two patients in a trial of Fialuridine for hepatitis B treatment. Trial managers and representatives for drug maker Eli Lilly met with officials the week of Jun 15, 1993 to discuss the trials, and possibly implications for the design of antiviral trials in general. Investigators say it is too soon to ban trials on this class of drugs.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
Ticking the right boxes
Article Abstract:
The reading-based Evolutec holds patent rights on a number of protein found in the saliva of ticks, with some already showing clinical promise, particularly for the treatment of allergies and inflammatory. The proteins' potency derived from a tick's need to evade detection while it feeds on its animal host with its saliva containing a number of molecules that suppress its victims immune response, allowing the tick to for days unnoticed.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Drug firms back-pedal on direct advertising
Article Abstract:
Pharmaceutical industry in the US has cut down on direct-to-consumer marketing of newly approved drugs to the public. This move by US drug companies is aimed at spending time to educate healthcare professionals about the drugs before an ad campaign begins.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 2005
User Contributions:
Comment about this article or add new information about this topic: